# Miltefosine for Children With PKDL

> **NCT02193022** · PHASE3 · COMPLETED · sponsor: **International Centre for Diarrhoeal Disease Research, Bangladesh** · enrollment: 80 (actual)

## Conditions studied

- Post Kala Azar Dermal Leishmaniasis

## Interventions

- **DRUG:** Miltefosine

## Key facts

- **NCT ID:** NCT02193022
- **Lead sponsor:** International Centre for Diarrhoeal Disease Research, Bangladesh
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2019-06-30
- **Final completion:** 2019-06-30
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2019-08-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02193022

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02193022, "Miltefosine for Children With PKDL". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02193022. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*